ALK-Abelló A/S (AKBLF)
OTCMKTS
· Delayed Price · Currency is USD
25.95
+0.64 (2.55%)
At close: May 15, 2025
ALK-Abelló Revenue
ALK-Abelló had revenue of 1.52B DKK in the quarter ending March 31, 2025, with 12.66% growth. This brings the company's revenue in the last twelve months to 5.71B, up 15.52% year-over-year. In the year 2024, ALK-Abelló had annual revenue of 5.54B with 14.78% growth.
Revenue (ttm)
5.71B DKK
Revenue Growth
+15.52%
P/S Ratio
7.09
Revenue / Employee
2.07M DKK
Employees
2,753
Market Cap
5.87B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.54B | 713.00M | 14.78% |
Dec 31, 2023 | 4.82B | 313.00M | 6.94% |
Dec 31, 2022 | 4.51B | 595.00M | 15.19% |
Dec 31, 2021 | 3.92B | 425.00M | 12.17% |
Dec 31, 2020 | 3.49B | 217.00M | 6.63% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
BioStem Technologies | 332.45M |
ALK-Abelló News
- 10 days ago - ALK-Abelló A/S (AKBLF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - ALK-Abelló A/S 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 14 days ago - ALK-Abelló A/S reports Q1 results - Seeking Alpha
- 19 days ago - ARS Pharmaceuticals signs agreement with ALK-Abelló A/S for neffy - Seeking Alpha
- 3 months ago - ALK-Abelló projects 9%-13% revenue growth for 2025 driven by global tablet expansion - Seeking Alpha
- 3 months ago - ALK-Abelló A/S (AKBLF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - ALK-Abelló A/S reports FY results - Seeking Alpha
- 6 months ago - Q3 2024 ALK-Abello A/S Earnings Call Transcript - GuruFocus